XML 93 R63.htm IDEA: XBRL DOCUMENT v3.23.3
ACCRUED EXPENSES - Vallon - Q1
 9 Months Ended
Sep. 30, 2023
Accrued Expenses [Line Items]  
ACCRUED EXPENSES ACCRUED EXPENSES
Accrued expenses consist of the following:
September 30, 2023December 31, 2022
Research and development$75 $— 
General and administrative188 — 
Payroll and related880 36 
Total accrued expenses$1,143 $36 
GRI Bio, Inc. (Formerly Vallon Pharmaceuticals, Inc.)  
Accrued Expenses [Line Items]  
ACCRUED EXPENSES ACCRUED EXPENSES
Accrued expenses consist of the following:
March 31, 2023December 31, 2022
Research and development$2 $42 
General and administrative136 268 
Payroll and related1,215 401 
Total accrued expenses$1,353 $711